# ClinicalTrials.gov record NCT07090343

> PeptideScanner retained ClinicalTrials.gov record NCT07090343 at 2026-07-30T18:24:37.186Z. Its registry update date was 2025-07-29, and PeptideScanner's reviewed identity mapping was semaglutide.

- Evidence object: `story:clinicaltrials-gov-nct07090343-semaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-07-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07090343-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07090343-semaglutide-v1.json
- Content SHA-256: `fdc89a06efbabb3688cc99cebde6cf457ef595f8fe775954ce8756d22bede392`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07090343 ([`ctg-observation-nct07090343-2025-07-29-e12ab2502f64`](#source-ctg-observation-nct07090343-2025-07-29-e12ab2502f64))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07090343 at 2026-07-30T18:24:37.186Z. Its registry update date was 2025-07-29, and PeptideScanner's reviewed identity mapping was semaglutide. ([`ctg-observation-nct07090343-2025-07-29-e12ab2502f64`](#source-ctg-observation-nct07090343-2025-07-29-e12ab2502f64))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07090343 at 2026-07-30T18:24:37.186Z. Its registry update date was 2025-07-29, and PeptideScanner's reviewed identity mapping was semaglutide. ([`ctg-observation-nct07090343-2025-07-29-e12ab2502f64`](#source-ctg-observation-nct07090343-2025-07-29-e12ab2502f64))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07090343-2025-07-29-e12ab2502f64`](#source-ctg-observation-nct07090343-2025-07-29-e12ab2502f64))

## Sources

<a id="source-ctg-observation-nct07090343-2025-07-29-e12ab2502f64"></a>
- **ClinicalTrials.gov record NCT07090343 · retained source version 2025-07-29:e12ab2502f64ff6a69574be8ddbdd95feac2b63eab8f86b6dbfefa3dcc09586b** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07090343) (`ctg-observation-nct07090343-2025-07-29-e12ab2502f64`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07090343." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07090343-semaglutide-v1.json SHA-256: fdc89a06efbabb3688cc99cebde6cf457ef595f8fe775954ce8756d22bede392.